Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04574518 · ClinicalTrials.gov registry record · NA

Teachable Moment to Opt-out of Tobacco: Interactive Voice Response Quit Line for Veteran Active Smokers With Lung Nodules

A NA study of Tobacco Use and Multiple Pulmonary Nodules, sponsored by VA Office of Research and Development.

Active
Registry status
NA
Development phase
223
Enrollment target
3
Study locations

NCT04574518 is a NA study of Tobacco Use and Multiple Pulmonary Nodules that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 223 participants, below the 376-participant average among 76 other Tobacco Use trials with a reported enrollment target (41% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04574518, a NA study of Tobacco Use and Multiple Pulmonary Nodules, is active but no longer recruiting, sponsored by VA Office of Research and Development.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
223 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to evaluate the effectiveness of a smoking cessation outreach intervention (TeaM OUT) on increasing use of smoking cessation resources in Veterans. The hypotheses are 1) patients included in the TeaM OUT group will have higher accession of cessation services, such as counseling and medication therapies, compared to patients in enhanced usual care and 2) more patients in the TeaM OUT group will have quit smoking at one year after the intervention. Veterans with a recently diagnosed lung nodule who currently smoke will receive the TeaM OUT intervention or Enhanced Usual Care. The TeaM OUT intervention has 2 parts: 1) a letter that a) describes the nodule and the importance of cessation related to the pulmonary nodule (i.e. teachable moment) and b) notification that a Proactive IVR Quit Line will initiate contact and 2) call(s) from the Proactive IVR Quit Line which a) offers smoking cessation resources and b) helps connect the patient to those resources. The enhanced usual care group will receive a letter that provides information about how to contact the IVR Quit Line. The IVR system will track referrals to cessation services. Additional information about smoking status and use of cessation resources will be collected from the electronic health record and surveys. .

Conditions Studied

Tobacco Use Multiple Pulmonary Nodules Solitary Pulmonary Nodule

Interventions

  • BEHAVIORAL Enhanced Usual Care
  • BEHAVIORAL TeaM OUT Intervention

Study Locations (3)

Minnesota

  • Minneapolis VA Health Care System, Minneapolis, MN - Minneapolis

Oregon

  • VA Portland Health Care System, Portland, OR - Portland

South Carolina

  • Ralph H. Johnson VA Medical Center, Charleston, SC - Charleston

Trial Details

FieldValue
Enrollment Target 223 participants
Start Date 2022-08-12
Est. Completion 2026-03-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04574518

The ClinicalTrials.gov registry entry for NCT04574518 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 76 other Tobacco Use trials with a reported enrollment target (41% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.

NCT04574518 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Minnesota, Oregon, South Carolina.

Frequently Asked Questions

What is clinical trial NCT04574518 about?

NCT04574518 is a clinical study titled "Teachable Moment to Opt-out of Tobacco: Interactive Voice Response Quit Line for Veteran Active Smokers With Lung Nodules". The purpose of this study is to evaluate the effectiveness of a smoking cessation outreach intervention (TeaM OUT) on increasing use of smoking cessation resources in Veterans. The hypotheses are 1) patients included in the TeaM OUT group will have higher accession of cessation services, such as cou...

What is the current status of trial NCT04574518?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 223 participants. The study started on 2022-08-12. Estimated completion is 2026-03-31.

What conditions does trial NCT04574518 study?

This clinical trial studies the following conditions: Tobacco Use, Multiple Pulmonary Nodules, Solitary Pulmonary Nodule.

What interventions are being tested in trial NCT04574518?

The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), TeaM OUT Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04574518?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04574518 being conducted?

This trial has 3 study locations across Minnesota, Oregon, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Tobacco Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Tobacco Use

All registered trials for this condition

Multiple Pulmonary Nodules

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.